Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold
- PMID: 33822092
- DOI: 10.1093/infdis/jiab178
Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold
Comment in
-
Reply to Kenyon.J Infect Dis. 2021 Nov 16;224(9):1624-1625. doi: 10.1093/infdis/jiab179. J Infect Dis. 2021. PMID: 33822079 No abstract available.
Comment on
-
The Mosaic mtr Locus as Major Genetic Determinant of Azithromycin Resistance of Neisseria gonorrhoeae-Germany, 2018.J Infect Dis. 2021 Oct 28;224(8):1398-1404. doi: 10.1093/infdis/jiab091. J Infect Dis. 2021. PMID: 33592101
-
Reply to Kenyon.J Infect Dis. 2021 Nov 16;224(9):1624-1625. doi: 10.1093/infdis/jiab179. J Infect Dis. 2021. PMID: 33822079 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous